Walvax Biotechnology Co., Ltd. (SHE: 300142)
China
· Delayed Price · Currency is CNY
13.03
0.00 (0.00%)
Dec 18, 2024, 3:04 PM CST
Walvax Biotechnology Revenue
Walvax Biotechnology had revenue of 708.00M CNY in the quarter ending September 30, 2024, a decrease of -28.51%. This brings the company's revenue in the last twelve months to 3.10B, down -31.76% year-over-year. In the year 2023, Walvax Biotechnology had annual revenue of 4.11B, down -19.12%.
Revenue (ttm)
3.10B
Revenue Growth
-31.76%
P/S Ratio
6.75
Revenue / Employee
1.30M
Employees
2,388
Market Cap
20.92B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 4.11B | -972.67M | -19.12% |
Jan 1, 2023 | 5.09B | 1.62B | 46.89% |
Jan 1, 2022 | 3.46B | 523.81M | 17.82% |
Dec 31, 2020 | 2.94B | 1.82B | 162.13% |
Dec 31, 2019 | 1.12B | 246.90M | 28.24% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full Definition